Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Gilead Sciences, Inc banner

Gilead Sciences, Inc
F:GIS

Watchlist Manager
Gilead Sciences, Inc Logo
Gilead Sciences, Inc
F:GIS
Watchlist
Price: 153.5 EUR 0.26% Market Closed
Market Cap: €191.2B
Write Note Create Alert

Bankruptcy Probability

Gilead Sciences, Inc's probability of bankruptcy is 1%, making a collapse highly unlikely. The solvency score is 64/100 — a warning sign of potential financial weakness.

We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.

Very Low
Probability of Bankruptcy

Financial Position

Cash & Short-Term Investments
+
3Y
-6%
5Y
+12%
10Y
-48%
Long-Term Investments
+
3Y
-
5Y
-
10Y
-
Debt
+
3Y
-
5Y
-
10Y
-

Solvency Ratios

Solvency Ratios Comparison
Gilead Sciences, Inc Competitors

Country Company Market Cap D/E D/A Interest
Coverage 		Altman
Z-Score 		Quick
Ratio 		Current
Ratio 		Cash
Ratio
US
Gilead Sciences, Inc
NASDAQ:GILD
208B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1.3T USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
AbbVie Inc
NYSE:ABBV
509.5B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
362.7B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
249B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
137.5B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
129B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
100.3B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Biogen Inc
NASDAQ:BIIB
36B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Moderna Inc
NASDAQ:MRNA
96.3B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
96.2B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Continue GIS Research

Summary
GIS intrinsic value, competitors valuation, and company profile.
DCF Valuation
GIS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GIS stock valuation using valuation multiples.
Wall St Estimates
GIS price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GIS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Gilead Sciences, Inc listings:
NASDAQ • USD
GILD
 XETRA • EUR
GIS
 XHAM • EUR
GIS
 BMV • MXN
GILD
 MIL • EUR
1GILD
 XMUN • EUR
GIS
 SWB • EUR
GIS
 DUS • EUR
GIS
 TSX • CAD
GILD
Discover More
Is Gilead Sciences, Inc at risk of bankruptcy?

Gilead Sciences, Inc's probability of bankruptcy is 1%, making a collapse highly unlikely.

The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does Gilead Sciences, Inc have?

As of the latest report, Gilead Sciences, Inc has no debt.

You can find a full breakdown on its Balance Sheet.

Back to Top
ALPHA SPREAD
Follow us
Join 363,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.